Immunotherapy company Harpoon Therapeutics has won a $70 million Series C funding round, with which it plans to expand its TriTAC and ProTriTAC platforms, the latter of which was unveiled just days…
Proscia is Fighting Cancer with Artificial Intelligence
It is a centuries-old image of good science: the lab-coated expert, hunched over a microscope analyzing a glass slide. Proscia wants to resign it to history – at least, when it comes…